Carcinoma in situ

rate for breast cancer according to race went to White women. Out of 100,000 women, 141.1 women were diagnosed with cancer. The second highest went to African Americans with 119.4 women. Out of 49,150 situ cases and 182,130 invasive cases in White women, there were 34,320 deaths. Out of 4,700 situ cases and 19,620 invasive cases in African American women, there were only 5, 670 (Smigal, 2006). Although the deaths in African American women differ in a huge amount, they are still the second highest

Ductal carcinoma in-situ (DCIS) DCIS is a pre-cancerous or non-invasive of malignant epithelial cells through the basement membrane into the surrounding tissue (Molinaro et al., 2016). DCIS includes five subtypes called comedo, papillary, micropapillary, cribriform and solid. The comedo subtype carries the higher probability of high nuclear grade and micro invasion (Tavassoli and Devilee, 2003). Invasive lobular carcinoma (ILC) ILC comprises 10 % of all invasive carcinoma and it is the second common

breast cancer can be cured. The second type is IDC or Invasive ductal carcinoma which is the common type of breast cancer. Invasive ductal carcinoma (IDC) starts in a milk duct of the breast, and goes through the wall of the duct then grows into the fatty tissue of the breast. This type of cancer can spread to other parts of the body through the lymphatic system and bloodstream. The thread type is Invasive lobular carcinoma (ILC), and it begins in the milk-producing glands. ILC is like IDC it

receptor (EGFR) and basal cytokeratins. Evaluation of pathologic response Specimens without a residual invasive tumor in both the breast and the regional lymph nodes were classified as a pathological complete response (pCR). Residual ductal carcinoma in situ was also included in the pCR category. Otherwise the specimens that did not achieve pCR category were classified as residual disease. Treatment protocol The chemotherapy regimen

One disease that many people associate negative connotation with today is cancer. The statistics tell us that cancer is still one of the leading causes of death today. In 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States and 595,690 people will die from the disease. However, the death rate has been declining as research into treatments has furthered. For example from 2004 to 2013 deaths from cancer has declined by 13%. Breast Cancer is a common type of breast

The term used to describe the benign condition that may have caused Ms. Barker's breast mass is benign breast disease (BBD. BBD is group of noncancerous breast conditions that causes irregular lumps, cysts, sensitive nipples, and itching (bk).According to Sangma, Panda, and Dasiah (2013), BBDs is classified as either pathological or clinical. Pathologically, BBDs is divided into non-proliferative lesions, proliferative lesions without atypia, and atypical proliferative lesions. Clinically, BBDs is

Breast Cancer 3 Running Head: Stages and Prognosis of Breast Cancer Stages and Prognosis of Breast Cancer Abstract Breast cancer is one of the major causes of death in cancer patients all over the world. Tumor node- metastasis (TNM) is a standard staging system for breast cancer. TNM staging system also provides the basis for the prognosis for breast cancer. The prognosis for breast cancer is majorly based on two factors; tumor size and biological factors. However, these factors have been further

cancer is responsible for 85% of lung cancer (Lungcancer, 2015). Non-small cell lung cancer can also be divided into 3 common types since their spreading behaviors and microscopic structures are different. Those three are squamous cell carcinoma, large cell carcinoma, and lastly adenocarcinoma (NIH National Cancer Institute, 2015). Among these three, Adenocarcinoma accounts for 40% of NSCLC, and it is known as the most common types of

Loss of primary cilia occurs early in breast cancer development Background Primary cilia are microtubule-based organelles that resemble hair-like projections, which extend from the plasma membrane on many types of normal eukaryotic cells. These eukaryotic cells with primary cilia exhibit a non-motile single cilium. The structure of the cilia comprises of a basal body that is anchored into the plasma membrane to nucleate microtubules. Intraflagellar transport (IFT) regulates ciliogenesis, or ciliary

Some of these include: Ductal Carcinoma in Situ, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer. Ductal Carcinoma in Situ (DCIS) is “a non-invasive cancer where abnormal cells have been found in the lining of the breast milk duct” [4] (National Breast Cancer Foundation). This form of cancer is non-invasive